• Revenues grew by 40% to $81.4 million
• EBITDA increased by 62% to $13.0 million
• Unfilled Contracted Orders remain robust at $53.8 million

Austco Healthcare Limited (Austco), a global leader in clinical communications solutions, announces record revenues and growing EBITDA and profits for FY25. Consistent with the company's guidance, total FY25 revenue was $81.4 million -- an increase of $23.3 million, or 40%, compared to FY24. This marks another record result, driven by both organic growth in existing operations and additional revenue from acquisitions. Software and SMA revenues increased by 3% (or $0.3 million) to $9.6 million in FY25. In FY25, gross margin was $42.4 million -- up $11.7 million, or 38%, compared to FY24. This growth was driven by higher overall revenue. EBITDA of $13.0 million in FY25 was up 62% from $8.1 million in FY24, driven by strong revenue growth and successful acquisitions. Net Profit Before Tax grew strongly in FY25, reaching $8.1 million compared to $5.7 million in FY24 and $1.8 million in FY23. Net Profit After Tax (NPAT) for FY25 was $5.9 million, compared to a record $7.1 million in FY24 and $2.3 million in FY23. The company's Unfilled Contracted Revenue (UCR) book now stands at $53.8 million at 13 August 2025, including a net $6.3 million from the recently acquired G&S. The company invested $4.8 million (FY24; $4.5 million) in research and development, of which $2.0 million was capitalised (FY24; $2.3 million).

Austco Healthcare expects to sustain earnings growth into FY26 and beyond, driven by strong market demand, an integrated product offering, and operational efficiencies.

The consistent growth trajectory and improved half-on-half stability position the company well for continued expansion. With strong market demand, an integrated product offering, and operational efficiencies flowing through to the bottom line, Austco is confident in its ability to sustain earnings growth into FY26 and beyond.